KLTO-202

N/A

Report date: 2025/09/19 17:43:17

Base Information

Drug NameKLTO-202
Drug Alias NameAAVmyo.desmin.s-KLKLTO-202
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsNeuromuscular DiseasesAmyotrophic Lateral SclerosisMultiple Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKlotho Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesKlotho Neurosciences Inc
Inactive CompaniesN/A
Active IndicationsNeuromuscular DiseasesAmyotrophic Lateral SclerosisMultiple Sclerosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A